Asymptomatic CMV viremia is associated with adverse outcomes following lung transplantation

被引：0
|
作者：
Lyu, D. M. [1 ]
Nicolls, M. [1 ]
Zamora, M. R. [1 ]
机构：
[1] Univ Colorado, Hlth Sci Ctr, Denver, CO USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2007年 / 26卷 / 02期
关键词：
D O I：
10.1016/j.healun.2006.11.259
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
241
引用
收藏
页码：S146 / S147
页数：2
相关论文
共 50 条
  • [31] CMV-Specific CD4+ T Cells in CMV-IgG-Seronegative Individuals Protect from CMV Viremia Following Transplantation with a CMV-Seropositive Donor Kidney
    Litjens, N.
    Huang, L.
    Dedeoglu, B.
    Meijers, R.
    Betjes, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 520 - 521
  • [32] Renal transplantation outcomes following heart and heart–lung transplantation
    L. Wong
    Y. R. Chee
    D. G. Healy
    J. J. Egan
    D. M. Sadlier
    Y. M. O’Meara
    Irish Journal of Medical Science (1971 -), 2017, 186 : 1027 - 1032
  • [33] Outcomes of Lung Transplantation Following Hematopoietic Stem Cell Transplantation
    Shitenberg, D.
    Rozengarten, D.
    Shostak, Y.
    Shtraichman, O.
    Bakal, I.
    Kramer, M. R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S257 - S258
  • [34] Effect of recurrent CMV viremia on graft and patient survival in renal transplantation
    Dobrer, Sabina
    Sherwood, Karen R.
    Davis, Kimberly
    Lan, James
    Gill, John
    Fisher, Anat
    Keown, Paul A.
    TRANSPLANTATION, 2024, 108 (9S)
  • [35] Early CMV Viremia Is Associated with Impaired Viral Control following Nonmyeloablative Hematopoietic Cell Transplantation with a Total Lymphoid Irradiation and Antithymocyte Globulin Preparative Regimen
    Schaenman, Joanna M.
    Shashidhar, Sumana
    Rhee, Chanu
    Wong, Jonathan
    Navato, Shelly
    Wong, Ruby M.
    Ho, Dora Y.
    Arai, Sally
    Johnston, Laura
    Brown, Janice M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (05) : 693 - 702
  • [36] Peripheral blood natural killer cells and CMV activation following lung transplantation
    Fildes, J. E.
    Walker, A. H.
    Thekkudan, J.
    Polster, K.
    Guiver, M.
    Yonan, N.
    Hutchinson, I. V.
    Leonard, C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (02): : S141 - S141
  • [37] Nighttime procedures are not associated with adverse outcomes in kidney transplantation
    Kienzl-Wagner, Katrin
    Schneiderbauer, Stefanie
    Boesmueller, Claudia
    Schneeberger, Stefan
    Pratschke, Johann
    Oellinger, Robert
    TRANSPLANT INTERNATIONAL, 2013, 26 (09) : 879 - 885
  • [38] Cytomegalovirus-associated CD57+KLRG1+CD8+TEMRA T cells are associated with reduced risk of CMV viremia in kidney transplantation and chronic allograft dysfunction in lung transplantation
    Pickering, Harry
    Arakawa-Hoyt, Janice
    Llamas, Megan
    Ishiyama, Kenichi
    Sun, Yumeng
    Parmar, Rajesh
    Sen, Subha
    Bunnapradist, Suphamai
    Hays, Steven R.
    Singer, Jonathan P.
    Schaenman, Joanna M.
    Lanier, Lewis L.
    Reed, Elaine F.
    Calabrese, Daniel R.
    Greenland, John R.
    HUMAN IMMUNOLOGY, 2025, 86 (03)
  • [39] ATG dose is associated with CMV viremia but not BK viremia in living donor kidney transplants.
    Ok, Ebru Sevinc
    Toz, Huseyin
    Ozgu, Isik Hasan
    Saracoglu, Ugur
    Ekin, Gokhan
    TRANSPLANTATION, 2024, 108 (09) : 233 - 233
  • [40] CURSE OF THE CURE: CMV VIREMIA IN ANCA-ASSOCIATED VASCULITIS
    Ali, Sana
    Zulfikar, Rafia
    Ahmed, Haroon
    CRITICAL CARE MEDICINE, 2020, 48
12345